Literature DB >> 16383333

Simultaneous determination of pKa and lipophilicity by gradient RP HPLC.

Paweł Wiczling1, Piotr Kawczak, Antoni Nasal, Roman Kaliszan.   

Abstract

High-performance methods of testing of drug candidates for properties of pharmacokinetics and pharmacodynamics importance, in particular lipophilicity and acidity, are necessary to overcome innovation stagnation in the pharmaceutical industry. Reversed-phase high-performance liquid chromatography (RP HPLC) might be a unique tool for the determination of both pKa and the apparent (pH-dependent) partition coefficient, applicable in high-throughput analysis of multicomponent mixtures, e.g., samples originating from automated synthesis. In this work, the pH/organic modifier gradient RP HPLC is presented as a means of simultaneous determination of an analyte's acidity and lipophilicity. The approach consists of retention measurements in a series of methanol gradient runs differing in pH range and duration of the gradient. Two different models of the influence of pH on retention in organic modifier gradient RP HPLC are compared regarding the quality of the simultaneously determined lipophilicity and dissociation constants. Advantages of the proposed approach over currently employed procedures are that it can be applied to compound mixtures, it requires only minute amounts of substances, and pKa values can be determined in the range 3-10 units and lipophilicity in the range 0-7 units. Verification of the reliability of the parameters determined by the new method was demonstrated on a series of 93 acidic and basic drug analytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16383333     DOI: 10.1021/ac0512103

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  7 in total

1.  Sclera-choroid-RPE transport of eight β-blockers in human, bovine, porcine, rabbit, and rat models.

Authors:  Rajendra S Kadam; Narayan P S Cheruvu; Henry F Edelhauser; Uday B Kompella
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-23       Impact factor: 4.799

2.  Solubility advantage of amorphous pharmaceuticals: II. Application of quantitative thermodynamic relationships for prediction of solubility enhancement in structurally diverse insoluble pharmaceuticals.

Authors:  Sharad B Murdande; Michael J Pikal; Ravi M Shanker; Robin H Bogner
Journal:  Pharm Res       Date:  2010-09-22       Impact factor: 4.200

3.  Influence of lipophilicity on drug partitioning into sclera, choroid-retinal pigment epithelium, retina, trabecular meshwork, and optic nerve.

Authors:  Rajendra S Kadam; Uday B Kompella
Journal:  J Pharmacol Exp Ther       Date:  2009-11-19       Impact factor: 4.030

4.  pKa determination of oxysophocarpine by reversed - phase high performance liquid chromatography.

Authors:  Huiling Huo; Tingting Li; Lei Zhang
Journal:  Springerplus       Date:  2013-06-20

5.  Contribution of ionic interactions to stationary phase selectivity in hydrophilic interaction chromatography.

Authors:  Martin Gilar; Kenneth D Berthelette; Thomas H Walter
Journal:  J Sep Sci       Date:  2022-04-07       Impact factor: 3.614

6.  Determination of the Physicochemical Properties of Piroxicam.

Authors:  Mustafa Çelebİer; Merve Nennİ; Ozan Kaplan; Emrah Akgeyİk; Mustafa Sinan Kaynak; Selma Şahİn
Journal:  Turk J Pharm Sci       Date:  2020-10-30

7.  Target-based drug discovery through inversion of quantitative structure-drug-property relationships and molecular simulation: CA IX-sulphonamide complexes.

Authors:  Petar Žuvela; J Jay Liu; Myunggi Yi; Paweł P Pomastowski; Gulyaim Sagandykova; Mariusz Belka; Jonathan David; Tomasz Bączek; Krzysztof Szafrański; Beata Żołnowska; Jarosław Sławiński; Claudiu T Supuran; Ming Wah Wong; Bogusław Buszewski
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.